357 related articles for article (PubMed ID: 18699745)
1. Campylobacter bacteremia: clinical features and factors associated with fatal outcome.
Pacanowski J; Lalande V; Lacombe K; Boudraa C; Lesprit P; Legrand P; Trystram D; Kassis N; Arlet G; Mainardi JL; Doucet-Populaire F; Girard PM; Meynard JL;
Clin Infect Dis; 2008 Sep; 47(6):790-6. PubMed ID: 18699745
[TBL] [Abstract][Full Text] [Related]
2. [A study of 30 patients with bacteremia due to Campylobacter spp].
Font C; Cruceta A; Moreno A; Miró O; Coll-Vinent B; Almela M; Mensa J
Med Clin (Barc); 1997 Mar; 108(9):336-40. PubMed ID: 9139156
[TBL] [Abstract][Full Text] [Related]
3. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
Ye Y; Li JB; Ye DQ; Jiang ZJ
Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for mortality of bacteremic patients in the emergency department.
Lin JN; Tsai YS; Lai CH; Chen YH; Tsai SS; Lin HL; Huang CK; Lin HH
Acad Emerg Med; 2009 Aug; 16(8):749-55. PubMed ID: 19594458
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
[TBL] [Abstract][Full Text] [Related]
7. Extraintestinal focal infections in adults with Salmonella enterica serotype Choleraesuis bacteremia.
Chen PL; Wu CJ; Chang CM; Lee HC; Lee NY; Shih HI; Lee CC; Ko NY; Wang LR; Ko WC
J Microbiol Immunol Infect; 2007 Jun; 40(3):240-7. PubMed ID: 17639165
[TBL] [Abstract][Full Text] [Related]
8. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
Deal EN; Micek ST; Ritchie DJ; Reichley RM; Dunne WM; Kollef MH
Pharmacotherapy; 2007 Feb; 27(2):191-9. PubMed ID: 17253909
[TBL] [Abstract][Full Text] [Related]
9. Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection.
Evans MR; Northey G; Sarvotham TS; Rigby CJ; Hopkins AL; Thomas DR
Clin Infect Dis; 2009 Jun; 48(11):1500-6. PubMed ID: 19400688
[TBL] [Abstract][Full Text] [Related]
10. Group A streptococcal bacteremia: outcome and prognostic factors.
Vallalta Morales M; Soriano Navarro CJ; Salavert Lletí M; Montero Alonso M; Pérez Bellés C; López Aldeguer J; Otero MC; Gobernado Serrano M
Rev Esp Quimioter; 2006 Dec; 19(4):367-75. PubMed ID: 17235407
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and risk factors for mortality in Morganella morganii bacteremia.
Lee IK; Liu JW
J Microbiol Immunol Infect; 2006 Aug; 39(4):328-34. PubMed ID: 16926980
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of prognostic and risk factors for mortality in polymicrobial bacteremia-fungemia in a university hospital: development over 10 years].
Ruiz-Giardín JM; Noguerado A; Pizarro A; Méndez J; La Hulla F; Fernández M; Hernández F; San Martín JV; Hernández I; Alvarez J; Salvanes F
Enferm Infecc Microbiol Clin; 2002 Nov; 20(9):435-42. PubMed ID: 12425877
[TBL] [Abstract][Full Text] [Related]
13. Campylobacter enteritis in children in northern Taiwan--a 7-year experience.
Wang SC; Chang LY; Hsueh PR; Lu CY; Lee PI; Shao PL; Hsieh YC; Yen FP; Lee CY; Huang LM
J Microbiol Immunol Infect; 2008 Oct; 41(5):408-13. PubMed ID: 19122923
[TBL] [Abstract][Full Text] [Related]
14. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
15. [Bacteraemia due to Campylobacter fetus in an immune suppressed patient].
Fica C A; Illanes R V; Sakurada Z A; Vidal C M; Valenzuela M ME
Rev Chilena Infectol; 2006 Dec; 23(4):336-9. PubMed ID: 17186081
[TBL] [Abstract][Full Text] [Related]
16. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain?
Raad I; Kassar R; Ghannam D; Chaftari AM; Hachem R; Jiang Y
Clin Infect Dis; 2009 Oct; 49(8):1187-94. PubMed ID: 19780661
[TBL] [Abstract][Full Text] [Related]
17. Bacteremia caused by antimicrobial resistant Campylobacter species at a medical center in Taiwan, 1998-2008.
Liao CH; Chuang CY; Huang YT; Lee PI; Hsueh PR
J Infect; 2012 Nov; 65(5):392-9. PubMed ID: 22771419
[TBL] [Abstract][Full Text] [Related]
18. [Campylobacter fetus bacteremia and cellulitis complicating a venous access port infection in an HIV infected patient].
Rapp C; Imbert P; Fabre R; Cavallo JD; Debord T
Med Mal Infect; 2007 May; 37(5):284-6. PubMed ID: 17446026
[TBL] [Abstract][Full Text] [Related]
19. Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis.
Chiu SK; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Aug; 41(4):286-93. PubMed ID: 18787734
[TBL] [Abstract][Full Text] [Related]
20. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia. Risk factors and outcome in the eastern region of Saudi Arabia.
Memon JI; Rehmani RS; Ahmed MU; Elgendy AM; Nizami IY
Saudi Med J; 2009 Jun; 30(6):803-8. PubMed ID: 19526164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
